Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients

High-dose chemotherapy and autologous stem cell transplantation (ASCT) have provided effective treatment for patients with newly diagnosed multiple myeloma for more than 3 decades; however, which patients will benefit from tandem ASCT compared with single ASCT remains unclear. Here we retrospectivel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Blocka, Joanna (VerfasserIn) , Hielscher, Thomas (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Hillengaß, Jens (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 March 2020
In: Biology of blood and marrow transplantation
Year: 2020, Jahrgang: 26, Heft: 7, Pages: 1280-1287
ISSN:1523-6536
DOI:10.1016/j.bbmt.2020.03.006
Online-Zugang:Verlag, lizenzpflichtig, Volltext: http://dx.doi.org/10.1016/j.bbmt.2020.03.006
Volltext
Verfasserangaben:Joanna Blocka, Thomas Hielscher, Hartmut Goldschmidt, Jens Hillengass

MARC

LEADER 00000caa a2200000 c 4500
001 1724851535
003 DE-627
005 20220818151335.0
007 cr uuu---uuuuu
008 200715s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.bbmt.2020.03.006  |2 doi 
035 |a (DE-627)1724851535 
035 |a (DE-599)KXP1724851535 
035 |a (OCoLC)1341345425 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Blocka, Joanna  |d 1987-  |e VerfasserIn  |0 (DE-588)1163754897  |0 (DE-627)1028116861  |0 (DE-576)508197856  |4 aut 
245 1 0 |a Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients  |c Joanna Blocka, Thomas Hielscher, Hartmut Goldschmidt, Jens Hillengass 
264 1 |c 16 March 2020 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.07.2020 
520 |a High-dose chemotherapy and autologous stem cell transplantation (ASCT) have provided effective treatment for patients with newly diagnosed multiple myeloma for more than 3 decades; however, which patients will benefit from tandem ASCT compared with single ASCT remains unclear. Here we retrospectively analyzed 978 trial and nontrial patients who underwent single or tandem ASCT in Heidelberg or other German-Speaking Myeloma Multicenter Group centers. Our results show that response improvement after first ASCT is a significant prognostic factor for progression-free survival benefit from tandem versus single ASCT (multivariable analysis, P=.002; hazard ratio,.64; 95% confidence interval,.48 to.85; P for interaction=.02). The depth of response after first ASCT and the cytogenetic profile did not have a significant prognostic effect on survival benefit from tandem ASCT. Our results suggest that it is not the response depth, but rather the response improvement after first ASCT is of prognostic significance regarding the benefit of tandem ASCT versus single ASCT. (c) 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/) 
650 4 |a criteria 
650 4 |a high-dose melphalan 
650 4 |a lenalidomide maintenance 
650 4 |a Myeloma 
650 4 |a Survival 
650 4 |a Tandem ASCT 
650 4 |a therapy 
650 4 |a Transplantation 
700 1 |a Hielscher, Thomas  |e VerfasserIn  |0 (DE-588)1159594791  |0 (DE-627)1022977768  |0 (DE-576)50506068X  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hillengaß, Jens  |d 1974-  |e VerfasserIn  |0 (DE-588)124918549  |0 (DE-627)368073823  |0 (DE-576)294568298  |4 aut 
773 0 8 |i Enthalten in  |t Biology of blood and marrow transplantation  |d [Erscheinungsort nicht ermittelbar] : Elsevier Health Sciences, 1998  |g 26(2020), 7, Seite 1280-1287  |h Online-Ressource  |w (DE-627)334374782  |w (DE-600)2057605-5  |w (DE-576)118352229  |x 1523-6536  |7 nnas  |a Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients 
773 1 8 |g volume:26  |g year:2020  |g number:7  |g pages:1280-1287  |g extent:8  |a Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients 
856 4 0 |u http://dx.doi.org/10.1016/j.bbmt.2020.03.006  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200715 
993 |a Article 
994 |a 2020 
998 |g 124918549  |a Hillengaß, Jens  |m 124918549:Hillengaß, Jens  |d 910000  |d 910100  |e 910000PH124918549  |e 910100PH124918549  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1159594791  |a Hielscher, Thomas  |m 1159594791:Hielscher, Thomas  |d 140000  |e 140000PH1159594791  |k 0/140000/  |p 2 
998 |g 1163754897  |a Blocka, Joanna  |m 1163754897:Blocka, Joanna  |d 910000  |d 910100  |e 910000PB1163754897  |e 910100PB1163754897  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1724851535  |e 3724558600 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.bbmt.2020.03.006"],"eki":["1724851535"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patientsBiology of blood and marrow transplantation","title":[{"title":"Biology of blood and marrow transplantation","subtitle":"BBMT ; the official journal of the American Society for Blood and Marrow Transplantation","title_sort":"Biology of blood and marrow transplantation"}],"note":["Gesehen am 16.03.2021"],"origin":[{"publisher":"Elsevier Health Sciences ; Carden Jennings","dateIssuedDisp":"[1998-2020]","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Charlottesville, Va."}],"pubHistory":["Volume 4, issue 1 (June 1998)-Volume 26, issue 12 (December 2020)"],"id":{"issn":["1523-6536"],"zdb":["2057605-5"],"eki":["334374782"]},"recId":"334374782","physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"26","extent":"8","issue":"7","text":"26(2020), 7, Seite 1280-1287","year":"2020","pages":"1280-1287"},"titleAlt":[{"title":"BBMT"}],"language":["eng"]}],"recId":"1724851535","physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Joanna Blocka, Thomas Hielscher, Hartmut Goldschmidt, Jens Hillengass"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients","title":"Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients"}],"origin":[{"dateIssuedDisp":"16 March 2020","dateIssuedKey":"2020"}],"note":["Gesehen am 15.07.2020"],"language":["eng"],"person":[{"given":"Joanna","role":"aut","family":"Blocka","display":"Blocka, Joanna"},{"given":"Thomas","role":"aut","family":"Hielscher","display":"Hielscher, Thomas"},{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"role":"aut","given":"Jens","display":"Hillengaß, Jens","family":"Hillengaß"}]} 
SRT |a BLOCKAJOANRESPONSEIM1620